- Home
- NTHI vs ELME Comparison
NTHI vs ELME Comparison
Compare NTHI & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | ELME |
|---|---|---|
| Founded | 2008 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.9M | 198.2M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | NTHI | ELME |
|---|---|---|
| Price | $7.98 | $2.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | 26.8K | ★ 1.2M |
| Earning Date | 02-23-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 35.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $206,360,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.20 | $1.98 |
| 52 Week High | $16.00 | $17.68 |
Technical Indicators
Market Signals| Indicator | NTHI | ELME |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 16.36 |
| Support Level | $5.25 | N/A |
| Resistance Level | $10.52 | $2.26 |
| Average True Range (ATR) | 0.70 | 0.04 |
| MACD | -0.18 | 0.12 |
| Stochastic Oscillator | 25.52 | 23.91 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.